Has Marc Goldstein, MD received payments from drug or device companies?

Yes. Drug and device makers reported $21,566 in general payments to Marc Goldstein, MD across 1,131 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Marc Goldstein, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Marc Goldstein, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Marc Goldstein, MD

Allergy & Immunology · Philadelphia, PANPI 1093863334

Payments from drug & device makers

$21,566in general payments, 2019–2025

Across 1,131 payments — averaging $19.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

GSK$4K
AstraZeneca$3K
CSL Behring$2K
Regeneron Healthcare Solutions, Inc.$2K
FFF Enterprises, Inc.$2K
Optinose US, Inc.$1K
plus $8K from 39 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
GSK	325	$4,442
AstraZeneca	107	$3,235
CSL Behring	108	$1,813
Regeneron Healthcare Solutions, Inc.	87	$1,542
FFF Enterprises, Inc.	3	$1,500
Optinose US, Inc.	76	$1,223
Sanofi	42	$950
Genentech USA, Inc.	47	$820
Pfizer	55	$721
Kaleo, Inc.	42	$712
Amgen	36	$702
Biocryst US Sales Co., LLC	23	$643
Takeda Pharmaceuticals U.S.A., Inc.	37	$634
Bio Products Laboratory USA, Inc.	21	$361
Novartis	21	$320
Grifols USA, LLC	10	$236
Incyte Corporation	5	$186
Teva Pharmaceuticals USA, Inc.	10	$157
Octapharma USA, Inc.	6	$128
LEO Pharma Inc.	8	$117
Electromed, Inc.	7	$96
Mylan Specialty L.p.	5	$94
ARS Pharmaceuticals Operations, Inc.	5	$91
Ionis Pharmaceuticals, Inc.	4	$77
Blueprint Medicines Corporation	4	$75
Azurity Pharmaceuticals, Inc.	3	$61
Sanofi-aventis U.S. LLC	1	$60
Shire North American Group Inc	4	$57
Boehringer Ingelheim	3	$56
Philips North America LLC	3	$55
Organon	3	$51
Genentech, Inc.	1	$50
Hikma Pharmaceuticals USA	3	$46
GC Biopharma USA, Inc.	2	$42
Verona Pharma, Inc.	1	$31
Alk-abello, Inc	2	$30
Eyevance Pharmaceuticals LLC	2	$26
Cycle Pharmaceuticals Inc	1	$23
Pharming Healthcare, Inc.	1	$18
Sun Pharmaceutical Industries Inc.	1	$17
Ambu Inc.	1	$15
ADMA Biomanufacturing LLC	2	$15
Bausch & Lomb, A Division Of Bausch Health US, LLC	1	$14
Merck	1	$11
Aimmune Therapeutics, Inc.	1	$11

How this compares

$21,566 in reported general payments places this provider in the 80th percentile of 175 allergy & immunology providers in Pennsylvania.

See all allergy & immunology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$1,069,042

Medicare patients

389

Services billed

37,017

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other allergy & immunology in Philadelphia

Drew WeissmanPhiladelphia$15.3M
Rahul DattaPhiladelphia$198K
Arnold LevinsonPhiladelphia$95K
John BossoPhiladelphia$86K
Elias AklPhiladelphia$80K
Neha SirohiPhiladelphia$62K
Raquel EmpedradPhiladelphia$21K
Karin Flynn-RoddenPhiladelphia$15K
Donald DvorinPhiladelphia$10K
Irene HaralabatosPhiladelphia$9K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →